These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 17990347)

  • 1. Moving forward in colorectal cancer research, what proteomics has to tell.
    Bitarte N; Bandrés E; Zárate R; Ramirez N; Garcia-Foncillas J
    World J Gastroenterol; 2007 Nov; 13(44):5813-21. PubMed ID: 17990347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomics for discovery of candidate colorectal cancer biomarkers.
    Alvarez-Chaver P; Otero-Estévez O; Páez de la Cadena M; Rodríguez-Berrocal FJ; Martínez-Zorzano VS
    World J Gastroenterol; 2014 Apr; 20(14):3804-24. PubMed ID: 24744574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneous nuclear ribonucleoprotein A1 is identified as a potential biomarker for colorectal cancer based on differential proteomics technology.
    Ma YL; Peng JY; Zhang P; Huang L; Liu WJ; Shen TY; Chen HQ; Zhou YK; Zhang M; Chu ZX; Qin HL
    J Proteome Res; 2009 Oct; 8(10):4525-35. PubMed ID: 19715280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic Profiling for Colorectal Cancer Biomarker Discovery.
    Álvarez-Chaver P; De Chiara L; Martínez-Zorzano VS
    Methods Mol Biol; 2018; 1765():241-269. PubMed ID: 29589313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mass spectrometry based translational proteomics for biomarker discovery and application in colorectal cancer.
    Ma H; Chen G; Guo M
    Proteomics Clin Appl; 2016 Apr; 10(4):503-15. PubMed ID: 26616366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative mass spectrometry for colorectal cancer proteomics.
    Martínez-Aguilar J; Chik J; Nicholson J; Semaan C; McKay MJ; Molloy MP
    Proteomics Clin Appl; 2013 Jan; 7(1-2):42-54. PubMed ID: 23027722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The proteomics of colorectal cancer: identification of a protein signature associated with prognosis.
    O'Dwyer D; Ralton LD; O'Shea A; Murray GI
    PLoS One; 2011; 6(11):e27718. PubMed ID: 22125622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarker discovery by proteomics-based approaches for early detection and personalized medicine in colorectal cancer.
    Corbo C; Cevenini A; Salvatore F
    Proteomics Clin Appl; 2017 May; 11(5-6):. PubMed ID: 28019089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomic Characterization of Colorectal Cancer Tissue from Patients Identifies Novel Putative Protein Biomarkers.
    Ludvigsen M; Thorlacius-Ussing L; Vorum H; Stender MT; Thorlacius-Ussing O; Honoré B
    Curr Issues Mol Biol; 2021 Sep; 43(2):1043-1056. PubMed ID: 34563043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probing the colorectal cancer proteome for biomarkers: Current status and perspectives.
    Lee PY; Chin SF; Low TY; Jamal R
    J Proteomics; 2018 Sep; 187():93-105. PubMed ID: 29953962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarker Identification through Proteomics in Colorectal Cancer.
    Martín-García D; García-Aranda M; Redondo M
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cancer secretome, current status and opportunities in the lung, breast and colorectal cancer context.
    Schaaij-Visser TB; de Wit M; Lam SW; Jiménez CR
    Biochim Biophys Acta; 2013 Nov; 1834(11):2242-58. PubMed ID: 23376433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of actin beta-like 2 (ACTBL2) as novel, upregulated protein in colorectal cancer.
    Ghazanfar S; Fatima I; Aslam M; Musharraf SG; Sherman NE; Moskaluk C; Fox JW; Akhtar MW; Sadaf S
    J Proteomics; 2017 Jan; 152():33-40. PubMed ID: 27989943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic and oncoproteomic advances in detection and treatment of colorectal cancer.
    McHugh SM; O'Donnell J; Gillen P
    World J Surg Oncol; 2009 Apr; 7():36. PubMed ID: 19338662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomic methodologies and their application in colorectal cancer research.
    Ikonomou G; Samiotaki M; Panayotou G
    Crit Rev Clin Lab Sci; 2009; 46(5-6):319-42. PubMed ID: 19958217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of aldolase A as a potential diagnostic biomarker for colorectal cancer based on proteomic analysis using formalin-fixed paraffin-embedded tissue.
    Yamamoto T; Kudo M; Peng WX; Takata H; Takakura H; Teduka K; Fujii T; Mitamura K; Taga A; Uchida E; Naito Z
    Tumour Biol; 2016 Oct; 37(10):13595-13606. PubMed ID: 27468721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A rat-to-human search for proteomic alterations reveals transgelin as a biomarker relevant to colorectal carcinogenesis and liver metastasis.
    Peng J; Zhang Q; Ma Y; Wang Y; Huang L; Zhang P; Chen J; Qin H
    Electrophoresis; 2009 Sep; 30(17):2976-2987. PubMed ID: 19711377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-depth proteomic delineation of the colorectal cancer exoproteome: Mechanistic insight and identification of potential biomarkers.
    Karagiannis GS; Pavlou MP; Saraon P; Musrap N; Xie A; Batruch I; Prassas I; Dimitromanolakis A; Petraki C; Diamandis EP
    J Proteomics; 2014 May; 103():121-36. PubMed ID: 24681409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immuno-proteomic discovery of tumor tissue autoantigens identifies olfactomedin 4, CD11b, and integrin alpha-2 as markers of colorectal cancer with liver metastases.
    Yang Q; Bavi P; Wang JY; Roehrl MH
    J Proteomics; 2017 Sep; 168():53-65. PubMed ID: 28669815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colorectal cancer proteomics, molecular characterization and biomarker discovery.
    Barderas R; Babel I; Casal JI
    Proteomics Clin Appl; 2010 Feb; 4(2):159-78. PubMed ID: 21137041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.